|
AU3090102A
(en)
*
|
2000-12-14 |
2002-06-24 |
Gen Probe Inc |
Method and kit for enhancing the association rates of polynucleotides
|
|
CA2494571C
(en)
*
|
2003-12-02 |
2010-02-09 |
F.Hoffmann-La Roche Ag |
Oligonucleotides containing molecular rods
|
|
WO2008008476A2
(en)
*
|
2006-07-12 |
2008-01-17 |
The Regents Of The University Of California |
Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups
|
|
RU2015151857A
(ru)
|
2008-12-02 |
2019-01-15 |
Уэйв Лайф Сайенсес Джапан, Инк. |
Способ синтеза модифицированных по атому фосфора нуклеиновых кислот
|
|
MX342945B
(es)
|
2009-07-06 |
2016-10-18 |
Ontorii Inc * |
Profármacos de ácido nucleico novedosos y métodos de uso de los mismos.
|
|
US10428019B2
(en)
|
2010-09-24 |
2019-10-01 |
Wave Life Sciences Ltd. |
Chiral auxiliaries
|
|
EP3348564A1
(en)
*
|
2011-05-10 |
2018-07-18 |
Bonac Corporation |
Process for preparing phosphate compound bearing isotope
|
|
EP3248982A1
(en)
|
2011-07-19 |
2017-11-29 |
Wave Life Sciences Ltd. |
Thiosulfonate reagents for the synthesis of functionalized nucleic acids
|
|
CA2879023C
(en)
|
2012-07-13 |
2017-03-28 |
Wave Life Sciences Japan |
Asymmetric auxiliary group
|
|
CA2879066C
(en)
|
2012-07-13 |
2019-08-13 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant
|
|
CN104661664B
(zh)
|
2012-07-13 |
2020-07-03 |
波涛生命科学有限公司 |
手性控制
|
|
CA2880869A1
(en)
|
2012-08-20 |
2014-02-27 |
The Regents Of The University Of California |
Polynucleotides having bioreversible groups
|
|
KR102285326B1
(ko)
|
2013-06-28 |
2021-08-04 |
에트리스 게엠베하 |
Rna를 세포에 도입하기 위한 조성물
|
|
US9410172B2
(en)
|
2013-09-16 |
2016-08-09 |
General Electric Company |
Isothermal amplification using oligocation-conjugated primer sequences
|
|
US10144933B2
(en)
|
2014-01-15 |
2018-12-04 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
|
JPWO2015108048A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
|
MX2016009290A
(es)
|
2014-01-16 |
2017-02-28 |
Wave Life Sciences Ltd |
Diseño quiral.
|
|
US20170056526A1
(en)
|
2014-02-26 |
2017-03-02 |
Ethris Gmbh |
Compositions for gastrointestinal administration of rna
|
|
EP3034539A1
(en)
|
2014-12-19 |
2016-06-22 |
Ethris GmbH |
Compositions for introducing nucleic acid into cells
|
|
KR20190058477A
(ko)
|
2016-08-17 |
2019-05-29 |
솔스티스 바이올로직스, 리미티드 |
폴리뉴클레오티드 구축물
|
|
AU2018252193B2
(en)
|
2017-04-14 |
2024-12-12 |
Tallac Therapeutics, Inc. |
Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use
|
|
WO2019006455A1
(en)
|
2017-06-30 |
2019-01-03 |
Solstice Biologics, Ltd. |
AUXILIARIES OF CHIRAL PHOSPHORAMIDITIS AND METHODS OF USE THEREOF
|
|
BR112020021037A2
(pt)
|
2018-04-25 |
2021-01-19 |
Ethris Gmbh |
Composição, composição sólida, processo para a preparação de uma composição, método para preservar uma formulação de nano ou micropartícula de um agente terapeuticamente ativo, uso de um composto selecionado de alcanos c3-c5 substituídos com um ou dois grupos hidróxi, e, dispositivo
|
|
EP4297722A1
(en)
|
2021-02-26 |
2024-01-03 |
Ethris GmbH |
Formulations for aerosol formation and aerosols for the delivery of nucleic acid
|
|
JPWO2022230990A1
(enExample)
*
|
2021-04-28 |
2022-11-03 |
|
|
|
JP2025529925A
(ja)
|
2022-08-26 |
2025-09-09 |
エスリス ゲーエムベーハー |
安定な脂質またはリピドイドナノ粒子懸濁液
|
|
EP4327829A1
(en)
|
2022-08-26 |
2024-02-28 |
Ethris GmbH |
Stabilization of lipid or lipidoid nanoparticle suspensions
|
|
WO2025045767A1
(en)
|
2023-08-25 |
2025-03-06 |
Ethris Gmbh |
Stabilized lipid and lipidoid nanoparticle formulations with specific surfactant properties for enhanced pharmaceutical applications
|